CD8A and neoplasm: In this study, we developed NeoScreen, an in vitro TIL expansion and screening methodology that aims at optimizing the sensitivity of antigen validation and also isolating rare tumor antigen-specific CD8 T cells for cloning of cognate TCRs from highly enriched tumor antigen-specific CD8 T cells.